Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Cresco Labs Inc. (6CQ.F) Follow Compare 0.7665 0.0000 (0.00%) As of 3:42:37 PM GMT+1. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Why Cresco Labs (CRLBF) Is Among the Best Pot Stocks To Invest In According to Analysts? We recently compiled a list of the 10 Best Pot Stocks To Invest In According to Analysts. In this article, we are going to take a look at where Cresco Labs (OTCQX:CRLBF) stands against other pot stocks to buy according to analysts. The global marijuana market is growing and the market for legal cannabis is […] Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024 Key Takeaways; Cannabis Sector Agrify announced $20 million financing and leadership changes in partnership with Green Thumb Industries TerrAscend reported revenue drop and expanded into Ohio with $10.3 million dispensary acquisition Curaleaf reported $44 million loss in Q3, despite securing a $40 million credit line to support growth Canopy Growth reported revenue drop and continued […] Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results CHICAGO, November 08, 2024--Cresco Labs Underlines the Successful Strategy Focused on Cash Flow with Third Quarter 2024 Financial Results Cresco Labs to Report Third Quarter 2024 Financial Results on November 8, 2024 CHICAGO, October 17, 2024--CRESCO LABS TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON NOVEMBER 8, 2024 Cresco Labs Announces Dennis Olis to Retire as Chief Financial Officer CHICAGO, September 12, 2024--Cresco Labs Announces Dennis Olis to Retire as Chief Financial Officer Cannabis stocks rise after Trump backs legalization measure in Fla. Cannabis stocks (CGC, TLRY, CURLF, CRLBF, GTBIF) are rising after former President Donald Trump announced he would vote in favor of Florida's ballot measure to legalize marijuana for recreational use. Market Domination Hosts Julie Hyman and Josh Lipton report more on the story and how cannabis stocks have performed this year so far. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl DEA sets date for marijuana rescheduling for after election Drug Enforcement Administration (DEA) officials has set the date for a hearing to possibly reclassify marijuana to a Schedule 1 drug on December 2, after the 2024 presidential election. Cannabis stocks, including Curaleaf (CURLF), Tilray (TLRY), Green Thumb (GTBIF), Cresco Labs (CRLBF), and Verano Holdings (VRNOF), are sliding on this news. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan. National Leading Vape Brand, Bloom, Partners With Cresco Labs to Launch Products in Florida NEW YORK, August 13, 2024--The Bloom Brand (Bloom), a national leading vape brand, announced a partnership today with Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) to expand distribution across the state of Florida. Launching in November 2024, Bloom’s Surf all-in-one vape will be exclusively produced by Cresco Labs in Florida and available at all 33 Sunnyside dispensaries throughout the Sunshine State. Florida is the seventh state in which Bloom products will be available to consumers. Bloom is 3 TSX Stocks That Might Be Undervalued In August 2024 The Canadian stock market has experienced significant volatility recently, with notable swings and a modest overall change despite dramatic headlines. Amid this turbulence, identifying undervalued stocks can be crucial for investors seeking opportunities in a fluctuating market. Cresco Labs Reports Consistent Profitability Improvement with Second Quarter 2024 Financial Results CHICAGO, August 08, 2024--Cresco Labs Reports Consistent Profitability Improvement with Second Quarter 2024 Financial Results Cresco Labs Launches Adult-Use Cannabis Distribution and Retail Sales in Ohio CHICAGO, August 06, 2024--Cresco Labs Launches Adult-Use Cannabis Distribution and Retail Sales in Ohio Cresco Labs to Report Second Quarter 2024 Financial Results on August 8, 2024 CHICAGO, July 23, 2024--CRESCO LABS TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 8, 2024 Cresco Labs Announces Voting Results of Its Annual General and Special Meeting of Shareholders CHICAGO, July 10, 2024--Cresco Labs Announces Voting Results of Its Annual General and Special Meeting of Shareholders Weekly Roundup on the Cannabis Sector & Psychedelic Sector Key Takeaways; Cannabis Sector Ayr Wellness reported solid first quarter results. Cresco Labs reported stagnant sales but an optimistic outlook for 2024. Tilray announced a $250 million equity offering to fund U.S. asset acquisitions amid legalization optimism. Flora Growth is strategizing on cannabis reform to its reverse financial trend. Key Takeaways; Psychedelic Sector Enveric Biosciences […] Cresco Labs Reports Continued Trend of Financial Improvement with First Quarter 2024 Financial Results CHICAGO, May 15, 2024--Cresco Labs Reports Continued Trend of Financial Improvement with First Quarter 2024 Financial Results Cresco Labs Announces May Conference Participation CHICAGO, May 09, 2024--Cresco Labs Announces May Conference Participation Will Cresco Labs Inc. (CRLBF) Report Negative Earnings Next Week? What You Should Know Cresco Labs Inc. (CRLBF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Cresco Labs to Report First Quarter 2024 Financial Results on May 15, 2024 CHICAGO, April 30, 2024--Cresco Labs to Report First Quarter 2024 Financial Results on May 15, 2024 Brokers Suggest Investing in Cresco Labs Inc. (CRLBF): Read This Before Placing a Bet The average brokerage recommendation (ABR) for Cresco Labs Inc. (CRLBF) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock? Despite Fast-paced Momentum, Cresco Labs Inc. (CRLBF) Is Still a Bargain Stock Cresco Labs Inc. (CRLBF) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen. Performance Overview Trailing total returns as of 2/27/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index Return 6CQ.F S&P/TSX Composite index YTD -0.84% +2.50% 1-Year -56.82% +18.35% 3-Year -86.36% +19.57%